5-Bromo-3-fluoro-2-(tetrahydro-2H-pyran-4-ylamino)benzonitrile

1-[2-[Bis(but-3-en-2-yloxy)methyl]hexylsulfonyl]-2-[(4-methoxyphenyl)methyl]-4-nitrobenzene

N-ethyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

(3-Methyl-2,5-dioxopyrrol-1-yl)methyl acetate

methyl (1R,2R,3S,3aR,8bS)-6-[[(2S,3R,6R)-6-[(1R)-1,2-bis(phenylmethoxy)ethyl]-3-methoxy-1,4-dioxan-2-yl]oxy]-1,8b-dihydroxy-8-methoxy-3a-(4-methoxyphenyl)-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-2-carboxylate

1H-Cyclopenta[b]benzofuran-2-carboxylic acid, 6-[[(2R,3R,6R)-6-[(1R)-1,2-bis(phenylmethoxy)ethyl]-3-methoxy-1,4-dioxan-2-yl]oxy]-2,3,3a,8b-tetrahydro-1,8b-dihydroxy-8-methoxy-3a-(4-methoxyphenyl)-3-phenyl-, methyl ester, (1R,2R,3S,3aR,8bS)-

2-Isopropoxybenzamidine hydrochloride

Combrestatin A4 metabolite M2

Combrestatin A4 metabolite M4

4,6-Pyrimidinediamine, N4-ethyl-5-nitro-N6-[4-(2-phenyldiazenyl)phenyl]-

5-Bromo-N-[(2-methylphenyl)methyl]-3-nitro-2-pyridinamine